Studying Health Outcomes After Treatment in Patients With Retinoblastoma
NCT03932786
This study is recruiting at 10 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Retinoblastoma
- Cancer Survivor
- Biological Sibling
- Intraocular Retinoblastoma
- Unilateral Retinoblastoma
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Last updated on ClinicalTrials.gov
- September 19, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 2
- Lurie Children's Hospital · Chicago, IL
- University of Illinois, Chicago · Chicago, IL
Minnesota · 1
- University of Minnesoa · Minneapolis, MN
Missouri · 1
- Washington School of Medicine at St. Louis · St Louis, MO
Ohio · 1
- Cincinnati Children's Hospital Medical Center · Cincinnati, OH
Pennsylvania · 1
- Children's Hospital of Philadelphia · Philadelphia, PA
Tennessee · 1
- Vanderbilt-Ingram Cancer Center · Nashville, TN
Texas · 2
- MD Anderson Cancer Center · Houston, TX
- Texas Childeren's Hospital · Houston, TX
Wisconsin · 1
- Children's Hospital of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.